UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer

Phase 2

Completed

Conditions: Musculoskeletal Complications
Recurrent Breast Cancer
Stage II Breast Cancer
Arthralgia
Pain
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage I Breast Cancer

Interventions: Drug: letrozole
Dietary Supplement: calcium carbonate
Other: laboratory biomarker analysis
Dietary Supplement: calcium citrate
Dietary Supplement: calcium glucarate
Drug: calcium gluconate
Dietary Supplement: cholecalciferol
Procedure: assessment of therapy complications
Procedure: musculoskeletal complications management/prevention

First Posted Date: 2006-12-28

Last Posted Date: 2017-07-11

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT00416715

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2

Completed

Conditions: Stage III Squamous Cell Carcinoma of the Nasopharynx
Stage III Squamous Cell Carcinoma of the Oropharynx
Stage III Squamous Cell Carcinoma of the Hypopharynx
Stage IV Squamous Cell Carcinoma of the Hypopharynx
Stage III Squamous Cell Carcinoma of the Larynx
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage IV Squamous Cell Carcinoma of the Larynx
Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage IV Squamous Cell Carcinoma of the Nasopharynx
Stage IV Squamous Cell Carcinoma of the Oropharynx

Interventions: Drug: erlotinib hydrochloride
Drug: cisplatin
Radiation: 3-dimensional conformal radiation therapy
Radiation: intensity-modulated radiation therapy
Procedure: quality-of-life assessment

First Posted Date: 2006-12-13

Last Posted Date: 2013-05-10

Lead Sponsor: University of Washington

Target Recruit Count: 204

Registration Number: NCT00410826

Locations: 🇺🇸
New Hanover Radiation Oncology Center, Wilmington, North Carolina, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States

and more 6 locations

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Stage IIIB Non-small Cell Lung Cancer
Recurrent Non-small Cell Lung Cancer
Malignant Pleural Effusion
Stage IV Non-small Cell Lung Cancer

Interventions: Drug: imatinib mesylate
Drug: paclitaxel

First Posted Date: 2006-12-07

Last Posted Date: 2017-04-25

Lead Sponsor: University of Washington

Target Recruit Count: 34

Registration Number: NCT00408460

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Phase 2

Completed

Conditions: Stage IA Breast Cancer
Stage II Breast Cancer
Stage IIIC Breast Cancer
Stage IB Breast Cancer
Stage IIIA Breast Cancer
HER2-positive Breast Cancer
Stage IV Breast Cancer
Estrogen Receptor-positive Breast Cancer
Stage IIIB Breast Cancer

Interventions: Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Biological: filgrastim
Drug: paclitaxel albumin-stabilized nanoparticle formulation
Biological: trastuzumab
Other: laboratory biomarker analysis
Procedure: quality-of-life assessment

First Posted Date: 2006-12-05

Last Posted Date: 2017-08-31

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT00407888

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Pedestrian Behavior Following Implementation of a Walking School Bus

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Walking School Bus Program

First Posted Date: 2006-11-22

Last Posted Date: 2024-05-09

Lead Sponsor: University of Washington

Target Recruit Count: 735

Registration Number: NCT00402701

Locations: 🇺🇸
Harborview Injury Prevention Research Center - University of Washington, Seattle, Washington, United States

Oral Androgens in Man-4: (Short Title: Oral T-4)

Phase 1

Completed

Conditions: Contraception

Interventions: Drug: Testosterone Enanthate
Drug: Dutasteride
Other: placebo sesame oil

First Posted Date: 2006-11-14

Last Posted Date: 2008-09-22

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00399165

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve

Phase 3

Terminated

Conditions: Heart Arrest

Interventions: Other: Analyze early
Other: Analyze later
Device: Impedance Threshold Device (ITD)
Device: Sham ITD

First Posted Date: 2006-11-01

Last Posted Date: 2018-08-09

Lead Sponsor: University of Washington

Target Recruit Count: 11738

Registration Number: NCT00394706

Locations: 🇺🇸
Alabama Resuscitation Center, Birmingham, Alabama, United States
🇺🇸
UCSD-San Diego Resuscitation Center, San Diego, California, United States
🇺🇸
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University, Portland, Oregon, United States

and more 6 locations

Behavioral Sleep Intervention in Adult Family Homes

Phase 2

Completed

Conditions: Dementia

Interventions: Behavioral: Sleep Education Program

First Posted Date: 2006-10-29

Last Posted Date: 2012-06-14

Lead Sponsor: University of Washington

Target Recruit Count: 47

Registration Number: NCT00393627

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

Completed

Conditions: Metastatic Cancer
Prostate Cancer

First Posted Date: 2006-10-26

Last Posted Date: 2017-03-13

Lead Sponsor: University of Washington

Target Recruit Count: 11

Registration Number: NCT00392938

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Short Course Nitrofurantoin for Acute Cystitis

Phase 2

Completed

Conditions: Urinary Tract Infection

Interventions: Drug: Nitrofurantoin 100mg twice daily x 5 days
Drug: TMP/SMX DS twice daily x 3 days

First Posted Date: 2006-10-24

Last Posted Date: 2014-06-05

Lead Sponsor: University of Washington

Target Recruit Count: 338

Registration Number: NCT00391651

Locations: 🇺🇸
University of WA, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy